Rejection of drug a blow for Australians living with Alzheimer’s disease
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
A new treatment for people living with the early stages of Alzheimer’s disease or mild cognitive impairment has been rejected by the Therapeutic Goods Administration (TGA).
With Dementia becoming the leading cause of death in Australia, it’s disappointing news for those impacted by Alzheimers.
Guest: Dr Kaele Stokes is Dementia Australia’s Executive Director – Services, Advocacy & Research.
Presenter: Warren Andrew.
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
RECENT PODCAST
Dr Sam Arnold: Autistic Burnout
Autistic burnout is not just tiredness. It can be a prolonged, life-altering depletion linked to sensory overload and masking. Sam ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 10:10 — 14.0MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Associate Professor Lauren Rosewarne: Why Libraries Are Booming Again
Libraries are busier than they have been in years, and they are no longer just about books. Associate Professor Lauren ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 15:21 — 21.1MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Tomáš Kantor: SUGAR at the 2026 Midsumma Festival
SUGAR is a bold one-person show about desire, money and pop culture fantasies, where glamour and pop songs sit alongside ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 8:51 — 12.2MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS